Home Page
Chairman's Letter
Committees
Opening Lectures
International Society of Heart
Failure Awards

Thanks

General Information
Social Program
List of Exhibitors
Scientific Program
Satellite Symposium
Monday, July 10, 2000
Registration Form
Accommodation
Form (Word Document)
Back to CARDIOLOGY ONLINE
  SCIENTIFIC PROGRAM

MONDAY,
JULY 10, 2000

TUESDAY, 
JULY 11, 2000

WEDNESDAY,
JULY 12, 2000

 

WEDNESDAY, JULY 12, 2000
08:30-10:15    HALL A
PL10:  Plenary Session:
SURGICAL APPROACH TO THE TREATMENT OF HEART FAILURE
Chairpersons: J.A. Elefteriades, New Haven CT, USA 
H.N. Sabbah, Detroit MI, USA
 
    Abstract Page
08:30  SHORT-TERM MECHANICAL SUPPORT FOR ACUTE HEART FAILURE (Invited Lecture)
D.M. Meyer, Dallas TX, USA
 115
08:45  MITRAL VALVE REPAIR AND LEFT VENTRICULAR ASSIST: A REASONABLE FORM OF THERAPY FOR TREATING ADVANCED HEART FAILURE (Invited Lecture)
M.A. Silver, M.S. Slaughter, P.S. Pappas, A.J. Tatooles, S. Szabo, Oak Lawn, IL, USA
 115
09:00  PASSIVE MECHANICAL CONTAINMENT OF PROGRESSIVE LEFT VENTRICULAR DILATION: A SURGICAL APPROACH TO THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah, P.A. Chaudhry, F. Kleber, W. Konertz, Detroit MI, USA, Berlin, Germany
 115
09:15  CONVENTIONAL SURGERY AS AN ALTERNATIVE TO TRANSPLANTATION FOR THE FAILING LEFT VENTRICLE (Invited Lecture)
J.A. Elefteriades, New Haven, CT, USA
 116
09:30  MANAGEMENT OF HEART FAILURE: CURRENT AND FUTURE SURGICAL CONCEPTS (Invited Lecture)
S. Hagl, Heidelberg, Germany
 116
09:45  TRANSPLANTATVASCULOPATHY AFTER HEART TRANSPLANTATION - INFLUENCE ON PATIENT SURVIVAL (Invited Lecture)
B. Heublein, K. Pethig, K. Besser, W. Harringer, A. Haverich, Hannover, Germany
 116
10:00  HEART TRANSPLANTATION-STATE OF THE ART TODAY: IS TROUGH LEVEL ADJUSTED MYCOPHENOLATE MOFETIL ADMINISTRATION MORE EFFICACIOUS IN COMBINATION WITH TACROLIMUS OR WITH CYCLOSPORINE? (Invited Lecture)
B.M. Meiser, T. Scheersoi, M. Pfeiffer, H. Treede, J. Schinner, D. Paulus, J. Koglin, H. Reichenspurner, W.V. Scheidt, B. Reichart, Munich, Germany
 116
10:15 GEOMETRIC ENDO-VENTRICULAR REPAIR OF DYSKINETIC LEFT VENTRICULAR SEGMENTS IMPROVES OUTCOME IN PATIENTS WITH POOR LEFT VENTRICULAR FUNCTION
J. Raman, S. Seevanayagam, G. Sakaguchi, B. Buxton, Heidelberg, Australia 
117
10:30  Coffee Break  
WEDNESDAY, JULY 12, 2000
08:30-10:15    HALL B
S69:  Session:
ROLE OF DIGITALIS, NITRATES AND BETA-BLOCKERS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: R. Pacher, Vienna, Austria 
Z. Schlesinger, Zrifin, Israel
 
    Abstract Page
08:30 HEMODYNAMIC AND PLASMA ATRAIL NATRIURETIC PEPTIDE RESPONSES TO ACUTE DIGITALIS THERAPY IN PATIENTS WITH NORMAL AND IMPAIRED LEFT VENTRICULAR FUNCTION
W.L. Miller, K.R. Bailey, S.A. Weston, J.C. Burnett, J. Rodeheffer, Rochester MN, USA
 117
08:45  ACUTE EFFECTS OF DIGITALIS ON HEMODYNAMICS AND CARDIAC NOREPINEPHRINE KINETICS IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
Y. Himura, T. Konishi, T. Tamura, H. Kondou, C. Izumi, M. Inoko, S. Kitaguchi, T. Hirozane, K. Iga, H. Gen, Tenri, Japan 
117
09:00  CYTOKINE NETWORK AND BETA-BLOCKER THERAPY IN PATIENTS WITH DILATED CARDIOMYOPATHY
T. Ohtsuka, M. Hamada, Y. Shigematsu, Y. Hara, M. Suzuki, O. Sasaki, G. Hiasa, H. Saeki, K. Hiwada, Ehime, Japan
 117
09:15  CARDIOPROTECTION FOR DUCHENNE MUSCULAR DYSTROPHY
Y. Ishikawa, H. Ogata, J.R. Bach, Y. Ishikawa, K. Ito, R. Minami, Yakumo, Japan
 118
09:30  MILRINONE ASSISTED B-BLOCKER TITRATION: LONG-TERM FOLLOW-UP
V. Just, C. Antonio, C. Kumbar, M.A. Papp, Chicago IL, USA 
118

 

09:45  THE ANTI-OXIDANT EFFECT OF CARVEDILOL CORRELATES WITH THE CLINICAL OUTCOME IN CONGESTIVE HEART FAILURE AND PREDICTS IT
E. Goldhammer, S. Shnitzer, T. Kagan, N. Kleiman, A. Lanir, E.G. Abinader, Haifa, Israel 
118

 

10:00  ADDITIONAL BENEFIT OF ORAL MOLSIDOMINE IN PATIENTS WITH LEFT VENTRICULAR FAILURE ALREADY TREATED WITH A STANDARD THERAPY
W. Grosse-Heitmeyer, A. Osterloh, S. Gemen, T. Huber, Lingen, Germany 
118
10:15  Coffee Break  
WEDNESDAY, JULY 12, 2000
10:45-12:30    HALL A
PL11:  Plenary Session:
RESULTS OF NEW CLINICAL TRIALS IN HEART FAILURE
Chairpersons: S.A. Rubin, Santa Monica CA, USA
U. Thadani, Oklahoma City OK, USA
 
    Abstract Page
10:45  LESSONS FROM FLOSEQUINAN: AN EXAMINATION OF HEART FAILURE DRUG RESEARCH AND THE FDA REGULATORY REVIEW PROCESS (Invited Lecture)
S.A. Rubin, Los Angeles CA, USA
 119
11:00  NEW DRUG THERAPIES FOR HEART FAILURE (Invited Lecture)
R.E. Hobbs, Cleveland OH, USA
 119
11:15  BETA-BLOCKADE IN SEVERE ENDSTAGE HEART FAILURE: IS THERE ENOUGH EVIDENCE? (Invited Lecture)
R. Pacher, Vienna, Austria
 119
11:30  CHANGING PHARMACOTHERAPY FOR HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION - IMPACT OF NEW CLINICAL TRIAL RESULTS (Invited Lecture)
U. Thadani, Oklahoma City OK, USA
 119
11:45  ECONOMIC AND QUALITY OF LIFE OUTCOMES ASSESSMENT IN HEART FAILURE TRIALS (Invited Lecture)
W.S. Weintraub, Atlanta GA, USA
 120
12:00  VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION: EFFECTS OF AT1 RECEPTOR BLOCKADE (Invited Lecture)
B.I. Jugdutt, Edmonton AB, Canada 
120
12:15  CLINICAL TRIALS IN HEART FAILURE. IS THERE A CONSENSUS? (Invited Lecture)
O. Abdel-Aziz, Cairo, Egypt
 120
WEDNESDAY, JULY 12, 2000
10:45- 12:45    HALL B
  S71: Session:
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, LEFT VENTRICULAR ASSIST DEVICES
Chairpersons: S. Hagl, Heidelberg, Germany 
D.M. Meyer, Dallas Texas, USA
 
    Abstract Page
10:45  PASSIVE VENTRICULAR CONSTRAINT; AN EFFECTIVE INTERVENTION FOR THE TREATMENT OF BOTH MODERATE AND SEVERE DILATED CARDIOMYOPATHY
M. Byrne, J. Raman, J. Power, C. Alferness, Melbourne, Australia, St. Paul MN, USA
 120
11:00  DYNAMIC BIOLOGIC ASSISTANCE WITH LATISSIMUS DORSI IN HEART FAILURE
J. Trainini, A. Christen, H. Schalet, S. Chada, J. Barisani, B. Elencwajg, J. Mouras, Buenos Aires, Argentina
 121
11:15  VENTRICULAR CONTAINMENT AS AN ADJUNCTIVE PROCEDURE IN ISCHEMIC CARDIOMYOPATHY - RESULTS OF THE PHASE I STUDY
J. Raman, S. Seevanayagam, J.M. Power, D. Hare, B. Buxton, C. Alferness, Heidelberg, Australia
 121
11:30 SHOULD ALL LEFT VENTRICULAR ASSIST DEVICE PATIENTS RECEIVE AUTOMATIC IMPLANTABLE DEFIBRILLATORS?
C.E. Lawless, M.H. Laff, K. Malinowska, G. Martin Mullen, B.A. Pisani, J.C. Mendez, B. Olshansky, Maywood IL, USA
 121
11:45  MECHANICAL CIRCULATORY SUPPORT FOR THE TREATMENT OF CHILDREN WITH ACUTE MYOCARDITIS
B.W. Duncan, D.J. Bohn, A.M. Atz, J.W. French, P.C. Laussen, D.L. Wessel, Seattle VA, USA
 121
12:00  PHARMACOLOGICALLY ENHANCED SKELETAL MUSCLE AORTOMYOPLASTY IN SHEEP
A.K. Hasnat, E.T. Van Der Velde, M.H. Yacoub, London, UK 
122
12:15  OFF-PUMP CABG VS. ON-PUMP CABG IN PATIENTS WITH SEVERE DYSFUNCTION OF THE LEFT VENTRICLE
S.M. Tugtekin, V. Gulielmos, R. Cichon, M. Knaut, K. Matschke, U. Kappert, S. Schueler, Dresden, Germany
 122
12:30  SIGNIFICANCE OF LEFT VENTRICULAR LOADING BY AN ASSIST DEVICE FOR MYOCARDIAL FIBROSIS
J. Mueller, R. Meyer, S. Semmrau, Y. Weng, H. Bieda, R. Hetzer, Berlin, Germany
 122
WEDNESDAY, JULY 12, 2000
10:45-12:30    HALL C
S72:  Session:
CARDIAC PACING STRATEGIES IN HEART FAILURE
Chairpersons: Y. Charuzi, Los Angeles CA, USA
R. Zelis, Hershey PA, USA
 
    Abstract Page
10:45  VENTRICULAR RESYNCHRONIZATION THERAPY FOR HEART FAILURE PATIENTS USING NON-SIMULTANEOUS BIVENTRICULAR STIMULATION
C. Butter, A. Auricchio, C. Stellbrink, E. Fleck, J. Ding, A. Kramer, A. Maarse, R. Salo, J. Spinelli, St. Paul MN, USA, Berlin, Magdeburg, Aachen, Germany
 122
11:00  IMPROVEMENT IN CARDIAC OUTPUT WITH RIGHT VENTRICULAR OUTFLOW SEPTAL PACING IS INDEPENDENT OF PRE-EXISTING CONDUCTION DISEASE
M.C. Giudici, S.S. Barold, A. Moeller, C.J. Meierbachtol, Davenport IA, USA
 123
11:15  ENDOCARDIAL BIVENTRICULAR PACING
P. Jais, D.C. Shah, A. Takahashi, H. Doaurd, S. Garrigue, M. Hocini, H. Mayer, J. Clementy, Bordeaux-Pessac, France 
123
11:30  CAN VENTRICULAR RESYNCHRONIZATION OBVIATE THE NEED FOR A HEART TRANSPLANT? A PEAK OXYGEN UPTAKE PERSPECTIVE
H. Kirkels, M. Kloss, P. Bakker, A. Auricchio, V. Kadhiresan, P. Potty, A. Doelger, Utrecht, The Netherlands, St. Paul MN, USA
 123
11:45  DOES VENTRICULAR RESYNCHRONIZATION THERAPY IN HEART FAILURE PATIENTS CHANGE HEART RATE? RESULTS FROM A PLACEBO CONTROLLED STUDY
S. Sack, M. Block, D. Boecker, A. Auricchio, C. Stellbrink, G. Carlson, V. Kadhiresan, W. Hoersch, J. Spinelli, Essen, Germany, St. Paul MN, USA 
123
12:00  CONTRACTILITY RATE RESPONSIVE PACEMAKER: AN IMPORTANT STEP TOWARD AN ARTIFICIAL SINUS NODE FOR SEVERE CHRONOTROPIC INCOMPETENCE
J. Clementy, S. Garrigue, P. Jais, A. Kobeissi, P. Le Metayer, M. Hocini, M. Haissaguerre, Bordeaux, France
 124
12:15  MID-TERM RESULTS OF BIVENTRICULAR PACING FOR HEART FAILURE: CORRELATION BETWEEN CLINICAL AND HEMODYNAMIC DATA
S. Garrigue, S. Reuter, P. Bordachar, M. Hocini, P. Jais, M. Haissaguerre, J. Clementy, Bordeaux-Pessac, France 
124
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P501:  Poster Session:
MYOCARDIAL STUNNING, HIBERNATION AND PRECONDITIONING
 
Board No.    Abstract Page
ENHANCED ANGIOTENSIN II TYPE 2 RECEPTOR MRNA AND PROTEIN EXPRESSION DURING CARDIOPROTECTION INDUCED BY RECEPTOR BLOCKADE DURING ISCHEMIA-REPERFUSION IN ISOLATED WORKING RAT HEARTS
B.I. Jugdutt, Y. Xu, A.S. Clanachan, Edmonton AB, Canada
 124
LOW-DOSE ADENOSINE STRESS ECHOCARDIOGRAPHY IN DETECTION OF VIABLE POSTISCHEMIC MYOCARDIUM
A. Djordjevic-Dikic, M. Ostojic, B. Beleslin, I. Nedeljkovic, J. Stepanovic, S. Stojkovic, I. Saponjski, M. Nedeljkovic, G. Stankovic, Z. Petrasinovic, Belgrade, Yugoslavia
 124
REDOX REGULATION OF LEUKOCYTES AND ANTIOXIDATIVE SYSTEM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
A. Kratnov, M. Ilyin, Y. Patrunov, O. Khrustalev, V. Romanov, Yaroslavl, Russia 
125
WARNING OF A SYNDROME OF STUNNING MYOCARDIUM AT INTRACORONARY THROMBOLYSIS WITH THE HELP OF THE DONOR OF NO-GROUPS SODIUM NITROPRUSSIDUM IN BUCCAL DRUG FORM IN THE PATIENTS WITH AN ACUTE CORONARY SYNDROME
I.L. Ketchin, A.N. Materuchin, E.P. Fedorova, V.V. Nagorny, N. Neccanti, Zaporozhye, Ukraine
 125
DETECTION OF MYOCARDIAL VIABILITY BY HYPERBARIC OXYGEN TREATMENT AND ECHOCARDIOGRAPHY AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION
M. Dekleva, A. Neskovic, A. Vlahovic, V. Obradovic, B. Putnikovic, A. Djordjevic-Dikic, M. Ostojic, Belgrade, Yugoslavia 
125
DIAGNOSTIC VALUE OF EXERCISE-INDUCED ST-SEGMENT ELEVATION IN Q-WAVE LEADS IN PATIENTS AFTER FIRST MYOCARDIAL INFARCTION
M. Zielinska, W. Koniarek, M. Maciejewski, H. Bolinska, Lodz, Poland
 125
PRECONDITIONING IN UNSTABLE ANGINA PATIENTS TREATED WITH MORPHINE
P. Burduk, P.K. Burduk, G. Drewa, P. Guzik, M. Bronisz, M. Jazdon, Bydgoszcz, Poznan, Poland
 126
ISCHEMIC PRECONDITIONING ATTENUATES NF-k ACTIVATION AND GENE EXPRESSION OF INFLAMMATORY CYTOKINES IN ISCHEMIA-REPERFUSED RAT HEART
G. Hiasa, M. Hamada, S. Ikeda, A. Ogimoto, O. Sasaki, T. Ohtsuka, M. Suzuki, Y. Hara, Y. Shigematsu, K. Hiwada, Ehime, Japan
 126
WARM-UP PHENOMENON IN PATIENTS WITH CORONARY ARTERY DISEASE - A CLINICAL MODEL OF PRECONDITIONING?
W. Koniarek, M. Zielinska, H. Bolinska, Lodz, Poland 
126
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P502:  Poster Session:
ACUTE MYOCARDIAL INFARCTION: THROMBOLYSIS AND REPERFUSION
 
Board No.     Abstract Page
10  ULTRASOUND CAVITATION FOR ENHANCEMENT OF ENZYMATIC THROMBOLYSIS: A NOVEL APPROACH AND PROSPECTS FOR PRACTICAL IMPLEMENTATION
I.E. Adzerikho, A.G. Mrochek, V.T. Minchenya, A.I. Kulak, Minsk, Belarus
 126
11  NO BENEFIT OF STREPTOKINASE IN KILLIP CLASS III AND IV OF ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, M. Guran, P. Capraru, C. Teodorescu, M. Dan, A. Tatu-Chitoiu, A. Bumbu, O. Istratescu, M. Dorobantu, Bucharest, Romania
 127
12  NA + /H + INHIBITOR AMELIORATES ISCHEMIA REPERFUSION INJURY IN THE RAT HIND LIMB
Y. Hamada, T. Kanda, S. Ishikawa, S. Imai, R. Nagai, K. Matui, N. Ohashi, Y. Morishita, Maebashi, Tokyo, Osaka, Japan 
127
13  SIGNIFICANT HIGHER IN-HOSPITAL MORTALITY IN WOMEN WITH ACUTE MYOCARDIAL INFARCTION AND THROMBOLYTIC THERAPY AS COMPARED TO MEN
G. Tatu-Chitoiu, A. Tatu-Chitoiu, C. Teodorescu, A. Bumpu, P. Capraru, M. Dan, M. Guran, O. Istratescu-Wolkowski, M. Dorobantu, Bucharest, Romania 
127
14  EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH ST DEPRESSION ONLY ON THE INITIAL 12-LEAD ELECTROCARDIOGRAM
I.B.A. Menown, J. Allen, J. Anderson, A.A.J. Adgey, Belfast, UK
 127
15  THE ACTIVITY OF SUPEROXIDE DISMUTASE, CATALASE AND GLUTATHIONE PEROXIDASE IN RED BLOOD CELLS OF PATIENTS WITH ACUTE MYOCARDIAL ISCHEMIA
P. Burduk, P.K. Burduk, G. Drewa, P. Guzik, M. Bronisz, Bydgoszcz, Poznan, Poland 
128
16  THE CORRELATION BETWEEN QT DISPERSION AND INFARCT SIZE IN PATIENTS WITH Q WAVE ANTERIOR MYOCARDIAL INFARCTION: 3Q'S PATTERN
M. Zoghi, C. Gurgun, C. Ceyhan, O. Yavuzgil, E. Ercan, F. Ozerkan, A. Akilli, S. Payzin, M. Akin, Izmir, Turkey 
128
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P503:  Poster Session:
ANTITHROMBOTIC AND ANTIPLATELET ADJUNCTIVE THERAPY FOR PTCA
 
Board No.     Abstract Page
17  TIROFIBAN AND INTRACORONARY STENTING: EVALUATION OF A NEW PHARMACOLOGIC REGIMEN
T.M. Amidon, J.B. Amidon, J.M. Benson, D. Coffler, Bellevue, USA 
128
18  TRANSBRACHIAL APPROACH USING LOW DOSE OF HEPARIN CAN BE USEFUL APPROACH
H. Taguchi, T. Kawarabayashi, A. Tanaka, Y. Nishida, Y. Nishibori, T. Sakamoto, T. Shimada, A. Tahara, Osaka, Japan
 128
19  IS SUBSEQUENT HEPARINIZATION NECESSARY FOR PATIENTS WHO UNDERWENT SUCCESSFUL STENT IMPLANTATION IN ACUTE MYOCARDIAL INFARCTION?
M. Yanase, S. Nagasaka, H. Kawashima, M. Muto, Y. Takada, M. Oya, C. Takanaka, Hamamatsu, Japan
 129
20  RESTENOSIS PREVENTION AFTER PTCA WITH OMEGA-3 FATTY ACIDS: RESULTS OF THE RANDOMIZED "ESPRIT" STUDY
A. Maresta, M. Balducelli, R. De Caterina, M. Marzilli, E. Stragliotto, E. Varani, Ravenna, Italy
 129
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P504:  Poster Session:
HYPERTENSION AND HEART FAILURE, NEW THERAPEUTIC APPROACHES
 
Board No.     Abstract Page
21  ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN ARTERIAL HYPERTENSION BASED ON MITRAL E AND A WAVES TRANSIT TIMES TO THE OUTFLOW TRACT: A NEW COMPOSITE INDEX
S. Qirko, T. Goda, V. Gjini, E. Pavli, Tirana, Albania
 129
22  HORMONE REPLACEMENT THERAPY ON BLOOD PRESSURE, HEART RATE AND RENIN ANGIOTENSIN SYSTEM IN EARLY MENOPAUSED HYPERTENSIVE WOMEN
T. Makris, P. Krespi, A. Hatzizacharias, G. Stavroulakis, E. Batzoglou, D. Xanthis, P. Voyiatzi, C. Katsikas, M. Kyriakidis, Athens, Greece
 129
22  ROLE OF ACUTE INTERMITTENT PERITONEAL DIALYSIS IN RESISTANT CONGESTIVE HEART FAILURE
M. Sharma, H.K. Aggarwal, N. Nand, Rohtak, India
 130
24  DIASTOLIC DYSFUNCTION AND HEART FAILURE IN LONGITUDINAL STUDY OF ARTERIAL HYPERTENSION
J. Bruthans, P. Krupicka, Prague, Czech Republic 
130
25  EARLY LEFT VENTRICULAR FILLING IN ARTERIAL HYPERTENSION EVALUATED BY COLOR M-MODE DOPPLER ECHOCARDIOGRAPHY
S. Qirko, T. Goda, V. Gjini, E. Pavli, Tirana, Albania 
130
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P504:  Poster Session:
HYPERTENSION AND HEART FAILURE, NEW THERAPEUTIC APPROACHES (cont'd)
 
Board No.     Abstract Page
26  MITRAL RING MOTION IS AN INDEPENDENT PREDICTOR OF THE LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN ARTERIAL HYPERTENSION
S. Qirko, E. Pavli, M. Qirko, Tirana, Albania 
130
27  EFFECTS OF COMBINED TREATMENT OF FOSINOPRIL AND PRAVASTATIN ON RENAL AND ENDOTHELIAL FUNCTION IN PATIENTS WITH HYPERTENSION AND HYPERLIPIDEMIA
X. Zeng, Y. Lee, X. Zeng, Y. Zhao, Chengdu, China 
131
28  ECHOCARDIOGRAPHIC PROFILE OF ELDERLY HYPERTENSIVE PATIENTS WITH DIASTOLIC HEART FAILURE
M.A.V. Gatchalian, R.E. Ramboyong, E.C. Perez, E.S. Caguioa, D.R. Flores, E.T. Gatchalian, New Manila, Philippines
 131
29  INFLUENCE OF MONOTHERAPY WITH CAPOSID-50 AND COMBINATION OF CAPOSID-50 WITH MELATONIN THERAPY ON CIRCULATION VARIABLES AND THEIR CIRCADIAN CHRONOSTRUCTURE IN OLD HYPERTENSIVE PATIENTS
R.M. Zaslavskaya, N. Bijasilov, K.Z. Teibloom, Moscow, Russia, Aktyubinsk, Kazakhstan 
131
30  BETA- ADRENOBLOCKERS: MODERN ASPECTS OF USING IN THE CASE OF DYSFUNCTION OF THE LEFT VENTRICLE IN PATIENTS WITH POLYCYTHEMIA VERA AND HYPERTENSION
G.N. Gorokhovskaya, E. Peresechenski, T.I. Torkhovskaya, A.I. Martynov, E.S. Fortinskaya, V.V. Soboleva, N.M. Finashova, New York NY, USA, Moscow, Russia
 131
31  PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF RENAL ARTERY STENOSIS IN A CHILD WITH HYPERTENSIVE HEART DISEASE
C.-D. Liang, S.F. Ko, C.Y. Fang, Kaohsiumg, Taiwan-R.O.C. 
132
32  BLOOD PRESSURE AWARENESS IN AUSTRIA. A 20 YEAR EVALUATION, 1978 - 1998
A. Schmeiser-Rieder, U. Kunze, Vienna, Austria 
132
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P505:  Poster Session:
HEART FAILURE IN WOMEN
 
Board No.     Abstract Page
33  PREVALENCE OF HEART FAILURE IN HYPERTENSIVES COULD BE RELATED TO GENDER-AGEING DIFFERENCE IN SYSTOLIC BP
R. Costa, M. Crippa, I. Notaristefano, E. Chiari, R. Fariello, Brescia, Italy 
132
34  THE GENDER GAP IN OPTIMAL CARE FOR CONGESTIVE HEART FAILURE: RESULTS FROM A CANADIAN UNIVERSITY TEACHING HOSPITAL
J.G. Howlett, J. Stanley, M. Macdonald, D.E. Johnstone, Halifax NS, Canada
 132
35  ARE GENDER REFERRAL DIFFERENCES PREHOSPITAL-BASED?
M. Hochleitner, Innsbruck, Austria 
133
36  GENDER-RELATED DIFFERENCES IN AUTONOMIC MODULATION OF HEART RATE IN PATIENTS WITH CONGESTIVE HEART FAILURE
D. Aronson, A.J. Burger, Boston MA, USA 
133
WEDNESDAY, JULY 12, 2000
08:30-13:00    POSTER AREA
P506:  Poster Session:
MYOCARDITIS, CARDIOMYOPATHY
 
Board No.     Abstract Page
37  EXPERIMENTAL AUTOIMMUNE MYOCARDITIS: IMMUNOHISTOLOGICAL ANALYSIS OF FAS AND FAS-L EXPRESSION
P.D. Milosavljevic, M. Milenkovic, M. Dimitrijevic, M. Colic, Belgrade, Yugoslavia
 133
38  THE GIANT CELL MYOCARDITIS TREATMENT TRIAL AND REGISTRY: DESIGN AND METHODS
L.T. Cooper, Rochester MN, USA 
133
39  CLINICAL CHARACTERISTICS OF 35 PATIENTS WITH MYOCARDITIS IN 1982-1999
M. Yazawa, K. Yoshida, N. Kotooka, T. Morooka, T. Ryu, K. Yoshida, T. Ogata, S. Tsuji, T. Tokushima, K. Ohmori, T. Utsonomiya, S. Matsuo, Saga, Japan
 134
40  LARGE ANIMAL MODEL OF CHRONIC HEART FAILURE: HAEMODYNAMIC CHARACTERISATION BY CONDUCTANCE CATHETER
A.K. Hasnat, E.T. Van Der Velde, M.H. Yacoub, London, UK 
134
41  THE SCINTIGRAPHIC EVALUATION OF CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
H. Ogata, Y. Ishikawa, Y. Isikawa, H. Nakagawa, K. Hamabe, R. Minami, Sapporo, Japan
 134
42  CONGESTIVE CARDIOMYOPATHY IN THE CAT
S.-K. Liu, P.R. Fox, New York NY, USA, Chunan, Taiwan-R.O.C. 
134
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P506:  Poster Session:
MYOCARDITIS, CARDIOMYOPATHY (cont'd)
 
Board No.     Abstract Page
43  THE EFFECTS OF BETA BLOCKER ON VENTRICULAR STIFFNESS IN PATIENTS WITH CONGESTIVE HEART FAILURE
E.T. Mesquita, E. Maia, H. Cramer V. Rey, C. Subieta, F.C.C. deDeus, C.R. Guedes, P.A. Santos, C. Tavares, C. Eyer, Rio de Janeiro, Brazil
 135
44  CLINICAL AND INSTRUMENTAL PROGNOSTIC VARIABLES IN PATIENTS WITH DILATED CARDIOMYOPATHY
T. De, K.K.H. Siddique, B.M. Birla, Calcutta, India
 135
45  DOXORUBICIN-INDUCED CARDIOTOXICITY IN ADULTS WITH LYMPHOMAS AND HODGKIN'S DISEASE
L. Elbl, V. Chaloupka, S. Nehyba, M. Navratil, I. Vasova, J. Vorlicek, Brno-Bohunice, Czech Republic
 135
46  ROMANIAN DILATED CARDIOMYOPATHY REGISTER - PARTICULARITIES IN YOUNG PATIENTS (A)
R.V. Cioranu, E. Apetrei, M.I. Datcu, M.G. Stancu, R.I. Cristodorescu, B.N. Minescu, A.I. Florea, Bucharest, Romania
 135
47  QT DISPERSION IN DILATED CARDIOMYOPATHY
R.V. Cioranu, E. Apetrei, A.I. Florea, Bucharest, Romania
 136
48  IMPAIRMENT OF COGNITIVE FUNCTION IN MILD HEART FAILURE DUE TO IDIOPATHIC DILATED CARDIOMYOPATHY
G. Castelli, M. Ciaccheri, L. Cipriani, G. Moretti, V. Troiani, M. Cellerini, G. Zuccala, F. Mazzuoli, A. Zuppiroli, A. Dolara, Firenze, Rome, Italy
 136
49  THE RELATIONSHIP BETWEEN M-MODE ECHOCARDIOGRAPHIC FINDINGS AND HEART FAILURE NYHA CLASS IN PATIENTS WITH DILATED CARDIOMYOPATHY
G. Bajraktari, F. Hima, G. Dragusha, B. Xhaxho, S. Qirko, Prishtina, Kosovo, Tirana, Albania 
136
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P507:  Poster Session:
ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS
 
Board No.     Abstract Page
50  EFFICACY OF ENALAPRIL IN TREATMENT OF ISCHEMIC HEART DISEASE COMPLICATED WITH HEART FAILURE
V. Tashchuk, I. Ilashchuk, T. Kulyk, M. Demeshko, Chernivtsi, Ukraine 
136
51  EFFECTS OF COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITION AND ANGIOTENSIN II RECEPTOR ANTAGONISM ON NEUROHORMONAL ACTIVATION IN CHRONIC HEART FAILURE
L. Malaya, A. Korzh, T. Bondarenko, A. Zhmuro, Kharkov, Ukraine 
137
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P507:  Poster Session:
ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS (cont'd)
 
Board No.     Abstract Page
52  EFFECTS OF LOSARTAN AND PERINDOPRIL THERAPY ON THE ACTIVITY OF RENAL KALLICREIN-KININ AND DOPAMIN SYSTEMS, RENAL HEMODYNAMICS IN PATIENTS WITH CONGESTIVE HEART FAILURE
V.A. Almasov, O.D. Beliaeva, M.J. Sitnicova, E.V. Shlyakhto, St. Petersburg, Russia 
137
53  EFFECT OF CILAZAPRIL ON PATIENTS WITH MILD TO MODERATE HEART FAILURE
Y. He, C. Liu, Zhengzhou, China 
137
54  THE EFFECT OF ACE-INHIBITOR ENALAPRYL ON LIPID PEROXIDATION, ANTIOXIDANT PROTECTION IN PATIENTS WITH MYOCARDIAL INFARCTION COMPLICATED WITH THE HEART FAILURE
N. Tarassov, E. Malakhovich, N. Vorontsova, I. Zhuravieva, V. Grishchenko, L. Barbarash, Kemerovo, Russia
 137
55  HYDROCHLOROTHIAZIDE IN FIXED COMBINATION WITH RAMIPRIL OR CAPTOPRIL IN ESSENTIAL HYPERTENSIVES: SIMILARITIES, DIFFERENCES AND PERSPECTIVES IN PREVENTING HEART FAILURE
R. Costa, M. Crippa, I. Notaristefano, R. Fariello, Brescia, Italy
 138
56 EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR QUINAPRIL ON CLINICAL CONDITION, CARDIAC FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEART FAILURE
A.I. Martinov, O.B. Stepura, A.N. Gadjiev, R.E. Dubinskaya, Moscow, Russia
 138
57  THE QUALITY OF LIFE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH OR WITHOUT HEART FAILURE TREATED WITH ENALAPRIL VS. CAPTOPRIL, COMPARED TO THOSE CONVENTIONALLY TREATED
A.I. Rivis, D. Burghina, M. Purice, D. Milin, M. Mihalas, O. Tunea, R. Popa, A. Rivis, Timisoara, Romania
 138
58  INFLUENCE COMBINATION OF INDAPAMIDE AND LOSARTAN ON PLASMA POTASSIUM CONCENTRATION
V.V. Kolomiets, K.A. Bobrishev, Donetsk, Ukraine 
138
59  ACUTE AND CHRONIC MYOCARDITIS: COMBINATION THERAPY WITH ACE-INHIBITORS AND IMMUNOSUPPRESSORS
E. Calenici, O. Calenici, Chisinau, Moldova 
139
60  INFLUENCE OF MELATONIN UPON CIRCADIAN ORGANIZATION IN HEMODYNAMICS ON THE BACKGROUND OF ENALAPRIL THERAPY IN HYPERTENSIVE PATIENTS
R.M. Zaslavskaya, O.Z. Narmanova, M.M. Teibloom, Moscow, Russia, Chimkent, Kazakhstan
 139
61  ANGIOTENSIN-CONVERTING ENZYME INHIBITOR USE FOR HEART FAILURE HAS INCREASED THEN PLATEAUED DURING THE 1990s
E.F. Philbin, T.A. Rocco Jr., P.L. Jenkins, Rochester NY, USA
 139
62  EFFECTS OF AT1 RECEPTORS BLOCKADE ON HEART RATE VARIABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION
I. Zarkos, G. Livieratos, P. Sinnis, E.A. Thireos, Athens, Crete, Greece 
139
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P508:  Poster Session:
BETA-BLOCKERS IN HEART FAILURE
 
Board No.     Abstract Page
63  BETA-BLOCKERS IN HEART FAILURE: HOW TO PROVIDE THE OPTIMAL RESULTS?
T. Mandecki, L. Kulejewski, A. Wilczek-Banc, M. Piekarski, L. Szymanski, Katowice, Poland
 140
64  CARVEDILOL HAS IMPORTANT SYMPATHOINHIBITORY EFFECTS DURING EXERCISE IN HUMANS
R.B. Herman, V.T. Johgalingam, K.S. Chua, A.M. Mustafa, R. Husain, M. Choy, C.C. Lang, Andalas, Indonesia, Kuala Lumpur, Malaysia
 140
65  SPECT Tc 99m SESTAMIBI IN THE EVALUATION OF CARVEDILOL IN HEART FAILURE (CHF) TREATMENT. EFFECT ON CORONARY MICROCIRCULATION
A. Orea, V. Rebollar, J. Dorantes, R. Narvaez, C. Keims, V. Ochoa, A. Rangel, J. Oseguera, R. Navarrete, J. Sepulveda, O. Gonzalez, Mexico City, Mexico
 140
66  HEART FAILURE CLINIC IN A SMALL DISTRICT GENERAL HOSPITAL
U.D. Wijayawardhana, Grantham, UK
 140
67  PARAMETERS PREDICTING EFFECTS OF BISOPROLOL IN DILATED CARDIOMYOPATHY
T. De, K.K.H. Siddique, B.M. Birla, Calcutta, India
 141
68  EFFECT OF LONG-TERM CARVEDILOL TREATMENT ON ENDOTHELIAL DYSFUNCTION AND LIPID PEROXIDATION IN PATIENT WITH SEVERE HEART FAILURE
E.V. Shlyakhto, O.O. Bolshakova, M.Y. Sitnikova, St. Petersburg, Russia 
141
69  NONISCHEMIC HEART FAILURE: INFLUENCE OF DIVERS THERAPY ON LEFT VENTRICULAR REMODELING
A. Caraus, E. Vataman, T. Cuzor, M. Pasecinic, D. Lisii, Chisinau, Moldova
 141
70  RELATION OF FUNCTIONAL IMPROVEMENT DUE TO METOPROLOL TO SUBSEQUENT OUTCOME IN IDIOPATHIC DILATED CARDIOMYOPATHY
R. De Maria, A. Di Lenarda, A. Gavazzi, G. Sinagra, M. Parolini, Milan, Italy
 141
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P509:  Poster Session:
CARDIAC PACING IN HEART FAILURE
 
Board No.     Abstract Page
71  HEMODYNAMIC ASSESSMENT OF MULTISITE VENTRICULAR PACING BY PEAK ENDOCARDIAL ACCELERATION AND ECHOCARDIOGRAPHY IN PATIENTS WITH END-STAGE HEART FAILURE
S. Garrigue, P. Bordachar, S. Reuter, A. Kobeissi, G. Gaggini, J. Clementy, Bordeaux-Pessac, France 
142
72  MECHANISMS OF LEFT VENTRICULAR WALLS RESYNCHRONIZATION DURING MULTISITE VENTRICULAR PACING: DIRECT EFFECTS ON THE VARIATIONS OF THE REGIONAL ELECTROMECHANICAL DELAYS AND WALL MOTION VELOCITIES
S. Garrigue, S. Lafitte, M. Hocini, P. Jais, M. Haissaguerre, J. Clementy, Bordeaux-Pessac, France
 142
73  PACING FOR CONGESTIVE HEART FAILURE WHO WILL BENEFIT? WHERE TO PACE? AN ENDOVASCULAR APPROACH TO SCREENING
M.C. Giudici, B. Tockman, L. Liu, Davenport IA, St. Paul MN, USA 
142
74  SUB-MAXIMAL EXERCISE CAPACITY OF HEART FAILURE PATIENTS WITH POOR PROGNOSIS CAN BE IMPROVED BY VENTRICULAR RESYNCHRONIZATION THERAPY
S. Sack, F. Heinzel, A. Auricchio, V. Kadhiresan, A. Doelger, T. Pochet, St. Paul MN, USA
 142
75  RIGHT VENTRICULAR OUTFLOW TRACT PACING IMPROVES HEMODYNAMICS IN PATIENTS WITH CLASS III-IV HEART FAILURE AND EXISTING APICAL LEADS
M.C. Giudici, D.W. Orias, D.L. Paul, T.A. Devlin, C.J. Meierbachtol, Davenport IA, USA
 143
76  RISK FACTORS FOR LONG-TERM SURVIVAL FOLLOWING PERMANENT PACEMAKER IMPLANTATION
J.R. Pyatt, M. Somauroo, M. Jackson, R.K. Aggarwal, R.G. Charles, D.T. Connelly, Liverpool, UK
 143
77  TACHYCARDIA-MEDIATED CARDIOMYOPATHY DUE TO ATRIAL FIBRILLATION IS REVERSED WITH EITHER ABLATION/PACING OR CARDIOVERSION
K.J. VanWhy, M.C. Giudici, Davenport IA, USA
 143
78  DOES HEART RATE STABILIZATION IN PATIENTS WITH BIOTRONIK ACTROS S PACEMAKER AND CHRONIC ATRIAL FIBRILLATION IMPROVE HEMODYNAMIC PARAMETERS?
M. Chudzik, M. Maciejewski, M. Zielinska, J.K. Wranicz, I. Cygankiewicz, J. Zrobek, K. Bartczak, L. Wojtasik, Lodz, Poland
 143
79  OPTIMIZATION OF AV DELAY BY PULSED DOPPLER TISSUE IMAGING IN PATIENTS WITH DUAL-CHAMBER PACING
M. Gessner, G. Blazek, W. Kainz, M. Gruska, G. Gaul, Vienna, Austria 
144
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P509:  Poster Session:
CARDIAC PACING IN HEART FAILURE (cont'd)
 
Board No.     Abstract Page
80  CLOSED LOOP STIMULATION IN CHAGASIC PATIENTS WITH CONGESTIVE HEART FAILURE: CLINICAL RESULTS
O.T. Greco, A. Cardinalli Neto, R.V. Ardito, M. Schaldach, Sao Jose do Rio Preto, Brazil
 144
81 DOES PERMANENT RIGHT VENTRICULAR PACING IN RESTING PATIENTS WITH CHRONIC ATRIAL FIBRILLATION IMPROVE HEMODYNAMIC PARAMETERS GUIDED BY THORACIC ELECTRIC BIOIMPEDANCE?
M. Chudzik, J.K. Wranicz, I. Cygankiewicz, J. Zrobek, K. Bartczak, L. Wojtasik, W. Kargul, Lodz, Katowice, Poland
 144
82  DILATED CARDIOMYOPATHY AND DDD PACING
O.T. Greco, A. Cardinalli Neto, A. Parro Jr., J.V. Vitola, R.V. Ardito, Sao Jose Rio Preto, Brazil
 144
83  PERMANENT LEFT VENTRICULAR-BASED PACING IMPROVES MITRAL REGURGITATION IN PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE
M. Gilard, Y. Etienne, V. Valls-Bertault, J. Mansourati, J.-J. Blanc, Brest, France
 145
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P510:  Poster Session:
MECHANICAL SUPPORT, LEFT VENTRICULAR ASSIST DEVICES
 
Board No.     Abstract Page
84  PATIENTS WHO DEVELOP SIGNIFICANT CONTRAINDICATIONS TO HEART TRANSPLANT WHILE ON LEFT VENTRICULAR ASSIST DEVICE SHOULD NOT BE TRANSPLANTED
G.M. Mullen, K. Malinowska, B.A. Pisani, J.C. Mendez, J.A. Robinson, M. Bakhos, B.K. Foy, Maywood IL, USA 
145
85  ADAPTED EXTRACORPOREAL SUPPORT FOR HIGH RISK PTCA OF A CRUCIAL STENOSIS OF A SINGLE RESIDUAL CORONARY ARTERY
H.-G. Wollert, K. Ansorge, H. Grubitzsch, L. Eckel, Karlsburg, Germany
 145
86  OUTCOME OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION AS A BRIDGE TO HEART TRANSPLANTATION IN PATIENTS OVER SIXTY YEARS OLD
G.M. Mullen, K. Malinowska, M.H. Laff, L.K. Dusek, B.A. Pisani, J.C. Mendez, J.A. Robinson, R. Pifarre, M. Bakhos, B.K. Foy, Maywood IL, USA
 145
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P511:  Poster Session:
SURGERY FOR LV DYSFUNCTION
 
Board No.     Abstract Page
87  ENDOVENTRICULAR PATCH PLASTY ACCORDING TO DOR IN ISCHEMIC HEART DISEASE - EVALUATION OF CHANGES IN LEFT VENTRICULAR FUNCTION BY 3D TRANSESOPHAGEAL ECHOCARDIOGRAPHY
P. Hunold, T. Bartel, H. Jakob, R. Erbel, Essen, Germany 
146
88  DYNAMIC AORTOMYOPLASTY WITH LATISSIMUS DORSI IN HEART FAILURE
J. Trainini, B. Elencwajg, J. Barisani, J. de Paz, A. Christen, J. Mouras, H. Schalet, S. Chada, Buenos Aires, Argentina
 146
89  A NEW CONCEPT OF EXTRAMYOCARDIAL VENTRICULAR SUPPORT FOLLOWING FUNCTIONAL RECOVERY OF FAILING HEARTS AFTER ADYNAMIC CARDIOMYOPLASTY IN AN ANIMAL MODEL
R. Krakor, M. Mochalski, T. Kuntze, V. Falk, T. Rauch, R. Autschbach, F.-W. Mohr, Leipzig, Germany
 146
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P512:  Poster Session:
CARDIAC TRANSPLANTATION
 
Board No.     Abstract Page
90  OUTCOME OF HEART TRANSPLANTATION IN DIABETIC PATIENTS
G.M. Mullen, K. Malinowska, B.A. Pisani, J.C. Mendez, J.A. Robinson, M. Bakhos, B.K. Foy, Maywood IL, USA
 146
91  WITHDRAWING PREDNISONE AFTER HEART TRANSPLANTATION: RELATIONSHIP WITH ALLOGRAFT REJECTION AND DRUG SIDE EFFECTS AMONG CONSECUTIVE PATIENTS AT A SINGLE CENTER
E.F. Philbin, B. Czerska, D. Rickeard, G. Franklin, C. Drost, A. Asfour, C. Nelson, R.S.D. Higgins, A. Bernabei, Detroit MI, USA
 147
92  EVALUATION ACE INHIBITOR USE AND DOSAGE IN PATIENTS REFERRED FOR CARDIAC TRANSPLANTATION
G. Bhat, G. Ramaswamy, Louisville KY, USA 
147
93  TREATMENT OF DEEP INTRATHORACIC POSTOPERATIVE INFECTION WITH PROLONGED ANTIBIOTIC THERAPY AND MINIMAL TO NO SURGICAL DRAINAGE IN HEART TRANSPLANT RECIPIENTS
C.E. Lawless, K. Malinowska, D. Dilling, P.J. O'Keefe, G.M. Mullen, B.K. Foy, Maywood IL, USA
 147
94  EXTRACORPOREAL OXYGENATION IN SEVERE PULMONARY FAILURE - CASE REPORT AFTER HEART TRANSPLANTATION
H. Grubitzsch, K. Ansorge, H.-G. Wollert, L. Eckel, Karlsburg, Germany 
147
WEDNESDAY, JULY 12, 2000
08:30 - 13:00    POSTER AREA
P512:  Poster Session:
CARDIAC TRANSPLANTATION (cont'd)
 
Board No.     Abstract Page
95  IS SURVEILLANCE ENDOMYOCARDIAL BIOPSY NECESSARY IN LONG TERM HEART TRANSPLANT SURVIVORS?
G.M. Mullen, K. Malinowska, L.K. Dusek, D.J. Hulford, C.C. Cortez, L. Sajdak, B.A. Pisani, J.C. Mendez, J.A. Robinson, B.K. Foy, Maywood IL, USA
 148
96  RELATIONSHIP BETWEEN PREOPERATIVE SOCIAL WORK ASSESSMENT AND OUTCOMES IN CARDIAC TRANSPLANT RECIPIENTS
C.E. Lawless, L.K. Dusek, N. Jarecki, M. Myles, G. Mozdzierz, J.L. Maly, F. Hicks, K. Holm, K. Malinowska, G.M. Mullen, Maywood IL, USA
 148
97  THE DIAGNOSTIC AND PROGNOSTIC VALUE OF ROUTINE CORONARY ARTERIOGRAPHY AFTER CARDIAC TRANSPLANTATION
E.F. Philbin, A. Asfour, A. Greenbaum, B. Czerska, D. Rickeard, G. Franklin, C. Drost, R.S.D. Higgins, A. Bernabei, Detroit MI, USA 
148
98  OUTCOME OF HEART TRANSPLANTATION WITH HEPATITIS C ANTIBODY POSITIVE DONORS
G.M. Mullen, K. Malinowska, A.B. Pisani, J.C. Mendez, J.A. Robinson, M. Bakhos, B.K. Foy, Maywood IL, USA
 148